JP2000500737A5 - - Google Patents

Download PDF

Info

Publication number: JP2000500737A5
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

JP1997513269A

Other languages

English (en)

Other versions

JP2000500737A (ja

Filing date

1996-09-10

Publication date

2004-08-12

1995-09-11 Priority claimed from IL11524595A external-priority patent/IL115245A/en

1996-09-10 Application filed filed Critical

2000-01-25 Publication of JP2000500737A publication Critical patent/JP2000500737A/ja

2004-08-12 Publication of JP2000500737A5 publication Critical patent/JP2000500737A5/ja

Status Ceased legal-status Critical Current

Description

JP9513269A 1995-09-11 1996-09-10 腫瘍壊死因子α（ＴＮＦ−α）阻害性医薬品 Ceased JP2000500737A (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
IL115245		1995-09-11
IL11524595A IL115245A (en)	1995-09-11	1995-09-11	Tumor necrosis factor inhibiting pharmaceuticals
PCT/IL1996/000108 WO1997011668A2 (en)	1995-09-11	1996-09-10	TUMOR NECROSIS FACTOR ALPHA (TNF-α) INHIBITING PHARMACEUTICALS

Publications (2)

Publication Number	Publication Date
JP2000500737A JP2000500737A (ja)	2000-01-25
JP2000500737A5 true JP2000500737A5 (ja)	2004-08-12

Family

ID=11067971

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP9513269A Ceased JP2000500737A (ja)	1995-09-11	1996-09-10	腫瘍壊死因子α（ＴＮＦ−α）阻害性医薬品

Country Status (9)

Country	Link
US (3)	US5932610A (ja)
EP (1)	EP0876143B1 (ja)
JP (1)	JP2000500737A (ja)
AT (1)	ATE331503T1 (ja)
AU (1)	AU708886B2 (ja)
CA (1)	CA2231764A1 (ja)
DE (1)	DE69636308T2 (ja)
IL (1)	IL115245A (ja)
WO (1)	WO1997011668A2 (ja)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9726916D0 (en) *	1997-12-19	1998-02-18	Danbiosyst Uk	Nasal formulation
WO1999057106A1 (en) *	1998-05-04	1999-11-11	The University Of Connecticut	Novel analgesic and immunomodulatory cannabinoids
US7589220B2 (en) *	1998-06-09	2009-09-15	University Of Connecticut	Inhibitors of the anandamide transporter
US7897598B2 (en) *	1998-06-09	2011-03-01	Alexandros Makriyannis	Inhibitors of the anandamide transporter
US7276613B1 (en)	1998-11-24	2007-10-02	University Of Connecticut	Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US7161016B1 (en)	1998-11-24	2007-01-09	University Of Connecticut	Cannabimimetic lipid amides as useful medications
US6566560B2 (en)	1999-03-22	2003-05-20	Immugen Pharmaceuticals, Inc.	Resorcinolic compounds
JP2002539246A (ja)	1999-03-22	2002-11-19	イミュジェンファーマシューティカルズインコーポレイティッド	免疫疾患の治療
CA2387764A1 (en)	1999-10-18	2001-04-26	University Of Connecticut	Peripheral cannabinoid receptor (cb2) selective ligands
US7741365B2 (en) *	1999-10-18	2010-06-22	University Of Connecticut	Peripheral cannabinoid receptor (CB2) selective ligands
US7119108B1 (en) *	1999-10-18	2006-10-10	University Of Connecticut	Pyrazole derivatives as cannabinoid receptor antagonists
US8084467B2 (en) *	1999-10-18	2011-12-27	University Of Connecticut	Pyrazole derivatives as cannabinoid receptor antagonists
US6900236B1 (en)	1999-10-18	2005-05-31	University Of Connecticut	Cannabimimetic indole derivatives
US6943266B1 (en)	1999-10-18	2005-09-13	University Of Connecticut	Bicyclic cannabinoid agonists for the cannabinoid receptor
US7393842B2 (en) *	2001-08-31	2008-07-01	University Of Connecticut	Pyrazole analogs acting on cannabinoid receptors
US6808902B1 (en)	1999-11-12	2004-10-26	Amgen Inc.	Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
EP1267903A4 (en) *	2000-02-08	2003-08-06	Pharmacia Corp	METHODS OF TREATING GLAUCOMA
US6531128B1 (en)	2000-02-08	2003-03-11	Pharmacia Corporation	Methods for treating glaucoma
CA2408408C (en)	2000-05-12	2013-07-09	Genzyme Corporation	Modulators of tnf- alpha signaling
EP1785417A3 (en) *	2000-06-22	2007-08-01	Pharmos Corporation	Novel non-psychotropic cannabinoids
US7235584B2 (en) *	2000-06-22	2007-06-26	Pharmos Corporation	Non-psychotropic cannabinoids
EP1299374B1 (en) *	2000-06-22	2006-12-27	Pharmos Corporation	Novel non-psychotropic cannabinoids
AU2001296402A1 (en) *	2000-09-28	2002-04-08	Immugen Pharmaceuticals, Inc.	Methods and compounds for inhibiting eicosanoid metabolism and platelet aggregation
AU2002213429A1 (en) *	2000-09-28	2002-04-08	Immugen Pharmaceuticals, Inc.	Antiviral methods and compounds
JP2004532185A (ja) *	2001-01-26	2004-10-21	ユニバーシティオブコネチカット	新規なカンナビミメティックリガンド
CA2436133A1 (en)	2001-01-29	2002-08-08	University Of Connecticut	Receptor selective cannabimimetic aminoalkylindoles
JP4212470B2 (ja)	2001-06-26	2009-01-21	アムジェンフレモントインク．	Ｏｐｇｌへの抗体
US7057076B2 (en) *	2001-07-13	2006-06-06	University Of Connecticut	Bicyclic and tricyclic cannabinoids
EP1448557A4 (en) *	2001-10-26	2005-02-02	Univ Connecticut	HETEROINDANE: A NEW CLASS OF HIGH-ACTIVITY CANNABIMIMETIC LIGANDS
AU2003214226A1 (en) *	2002-03-18	2003-10-08	Immugen Pharmaceuticals, Inc.	Topical formulations of resorcinols and cannibinoids and methods of use
US20050137251A1 (en) *	2002-03-18	2005-06-23	Aaron Garzon	Dexanabinol and dexanabinol analogs regulate inflammation related genes
IL148736A0 (en) *	2002-03-18	2002-09-12	Pharmos Corp	Dexanabinol and dexanabinol analogs which regulate inflammation related genes
CA2496097A1 (en)	2002-08-23	2004-03-04	University Of Connecticut	Keto cannabinoids with therapeutic indications
US20050192341A1 (en) *	2002-09-05	2005-09-01	Seth Kindler	Non-psychotropic cannabinoids for prevention of cognitive impairment
PT1567138E (pt) *	2002-11-21	2011-04-11	Genzyme Corp	Utilização de derivados de diamida para inibição de rejeição crónica de transplante
WO2004047826A1 (en) *	2002-11-21	2004-06-10	Genzyme Corporation	Combination of diamide derivatives and immunosuppressive agents for induction of immune tolerance
JP2006509038A (ja) *	2002-12-04	2006-03-16	ファーモスコーポレイション	医薬組成物用の高エナンチオマー純度を有するデキサナビノール
ZA200802767B (en)	2005-09-29	2009-09-30	Amr Technology Inc	Process for production of delta-9-tetrahydrocannabinol
WO2009059277A1 (en) *	2007-11-02	2009-05-07	University Of South Florida	Synergistic modulation of microglial activation by nicotine and thc
GB0915877D0 (en)	2009-09-10	2009-10-14	E Therapeutics Plc	Cancer cell apoptosis
GB201207305D0 (en)	2012-04-26	2012-06-13	E Therapeutics Plc	Therapy
WO2015200049A1 (en)	2014-06-26	2015-12-30	Island Breeze Systems Ca, Llc	Mdi related products and methods of use
US9585867B2 (en)	2015-08-06	2017-03-07	Charles Everett Ankner	Cannabinod formulation for the sedation of a human or animal
WO2017068349A1 (en) *	2015-10-23	2017-04-27	E-Therapeutics Plc	Cannabinoid for use in immunotherapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL80411A (en) *	1986-10-24	1991-08-16	Raphael Mechoulam	Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them
US5284867A (en) *	1989-11-07	1994-02-08	Yissum Research Development Company Of The Hebrew University In Jerusalem	NMDA-blocking pharmaceutical compositions
US5338753A (en) *	1992-07-14	1994-08-16	Sumner H. Burstein	(3R,4R)-Δ6 -tetrahydrocannabinol-7-oic acids useful as antiinflammatory agents and analgesics
WO1994012667A1 (en) *	1992-11-27	1994-06-09	The United States Department Of The Army	Inhibitors of arachidonic acid metabolites for preventing neurological damage

1995
- 1995-09-11 IL IL11524595A patent/IL115245A/en not_active IP Right Cessation
1996
- 1996-09-10 AT AT96930337T patent/ATE331503T1/de not_active IP Right Cessation
- 1996-09-10 EP EP96930337A patent/EP0876143B1/en not_active Expired - Lifetime
- 1996-09-10 JP JP9513269A patent/JP2000500737A/ja not_active Ceased
- 1996-09-10 CA CA002231764A patent/CA2231764A1/en not_active Abandoned
- 1996-09-10 DE DE69636308T patent/DE69636308T2/de not_active Expired - Fee Related
- 1996-09-10 US US08/952,660 patent/US5932610A/en not_active Expired - Fee Related
- 1996-09-10 AU AU69420/96A patent/AU708886B2/en not_active Ceased
- 1996-09-10 WO PCT/IL1996/000108 patent/WO1997011668A2/en active IP Right Grant
1999
- 1999-05-26 US US09/318,774 patent/US6331560B1/en not_active Expired - Fee Related
2001
- 2001-10-04 US US09/971,821 patent/US6545041B2/en not_active Expired - Fee Related

Publication	Publication Date	Title
JP2000500033A5 (ja)	2004-09-09
JP2000500228A5 (ja)	2004-09-09
JP2000500445A5 (ja)	2004-10-14
JP2000500440A5 (ja)	2004-10-21
JP2000500327A5 (ja)	2005-10-06
JP2000500145A5 (ja)	2004-10-14
JP2000500155A5 (ja)	2004-10-21
JP2000500406A5 (ja)	2004-10-14
JP2000500361A5 (ja)	2004-10-14
JP2000502263A5 (ja)	2004-09-24
JP2000500115A5 (ja)	2004-07-08
JP2000500322A5 (ja)	2004-09-30
JP2000500258A5 (ja)	2004-08-12
JP2000500342A5 (ja)	2004-10-21
JP2000500192A5 (ja)	2004-07-15
JP2000500112A5 (ja)	2004-10-14
JP2000500397A5 (ja)	2004-10-21
JP2000500226A5 (ja)	2004-08-12
JP2000500051A5 (ja)	2004-10-14
JP2000500407A5 (ja)	2004-10-21
JP2000500125A5 (ja)	2004-10-21
JP2000500166A5 (ja)	2004-09-24
JP2000500257A5 (ja)	2004-08-12
JP2000500090A5 (ja)	2005-11-24
JP2000500346A5 (ja)	2005-06-16